Table 1.
Whole-genome sequencing and DNA sequence variant statistics
LFS-MB1 | LFS-MB2 | LFS-MB3 | LFS-MB4 | |
---|---|---|---|---|
Tumor bases sequenced | 109 × 109 | 120 × 109 | 37 × 109 | 143 × 109 |
Paired normal tissue bases sequenced | 116 × 109 | 125 × 109 | 17 × 109 | 114 × 109 |
Tumor physical coverage (span coverage) | 43.5× | 45.8× | 77.8× | 112.2× |
Paired normal physical coverage | 41.6× | 51.6× | 3.3× | 49.5× |
Tumor sequencing coverage | 30.8× | 34.6× | 8.9×* | 38.5× |
Paired normal sequencing coverage | 31.4× | 36.7× | 4.6×* | 34.4× |
Total somatic mutations (whole genome) | 3,716 | 3,053 | - | 2,494 |
Non-silent coding mutations (val./tested) | 24 (20/21) | 22 (19/20) | 18(−/−)* | 11 (8/10) |
Mutation rate per Mb | 1.29 | 1.06 | - | 0.88 |
In addition to whole-genome sequencing, whole-exome data was generated at 39× (tumor) and 37× (paired normal) coverage in this case.
‘−’, not assessed; val., validated.